EPHA3 and neoplasm: Furthermore, two of the amino acids targeted by mutations to define the EphA3 interface, V231D and N232I, are within the 8 amino acid sequence that is defined as the epitope through which the EphB4 H200 antibody acts to cause tumour cell death.